249 related articles for article (PubMed ID: 33469864)
1. Endothelial ERG alleviates cardiac fibrosis via blocking endothelin-1-dependent paracrine mechanism.
Zhang X; Hu C; Yuan YP; Song P; Kong CY; Wu HM; Xu SC; Ma ZG; Tang QZ
Cell Biol Toxicol; 2021 Dec; 37(6):873-890. PubMed ID: 33469864
[TBL] [Abstract][Full Text] [Related]
2. Endothelial cell-derived endothelin-1 promotes cardiac fibrosis in diabetic hearts through stimulation of endothelial-to-mesenchymal transition.
Widyantoro B; Emoto N; Nakayama K; Anggrahini DW; Adiarto S; Iwasa N; Yagi K; Miyagawa K; Rikitake Y; Suzuki T; Kisanuki YY; Yanagisawa M; Hirata K
Circulation; 2010 Jun; 121(22):2407-18. PubMed ID: 20497976
[TBL] [Abstract][Full Text] [Related]
3. Endothelial Forkhead Box Transcription Factor P1 Regulates Pathological Cardiac Remodeling Through Transforming Growth Factor-β1-Endothelin-1 Signal Pathway.
Liu J; Zhuang T; Pi J; Chen X; Zhang Q; Li Y; Wang H; Shen Y; Tomlinson B; Chan P; Yu Z; Cheng Y; Zheng X; Reilly M; Morrisey E; Zhang L; Liu Z; Zhang Y
Circulation; 2019 Aug; 140(8):665-680. PubMed ID: 31177814
[TBL] [Abstract][Full Text] [Related]
4. Cytokine-Mediated Degradation of the Transcription Factor ERG Impacts the Pulmonary Vascular Response to Systemic Inflammatory Challenge.
Schafer CM; Martin-Almedina S; Kurylowicz K; Dufton N; Osuna-Almagro L; Wu ML; Johnson CF; Shah AV; Haskard DO; Buxton A; Willis E; Wheeler K; Turner S; Chlebicz M; Scott RP; Kovats S; Cleuren A; Birdsey GM; Randi AM; Griffin CT
Arterioscler Thromb Vasc Biol; 2023 Aug; 43(8):1412-1428. PubMed ID: 37317853
[TBL] [Abstract][Full Text] [Related]
5. The role of endothelial autocrine NRG1/ERBB4 signaling in cardiac remodeling.
Dugaucquier L; Feyen E; Mateiu L; Bruyns TAM; De Keulenaer GW; Segers VFM
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H443-H455. PubMed ID: 32618511
[TBL] [Abstract][Full Text] [Related]
6. Endothelin-1 upregulation mediates aging-related cardiac fibrosis.
Wang X; Guo Z; Ding Z; Khaidakov M; Lin J; Xu Z; Sharma SG; Jiwani S; Mehta JL
J Mol Cell Cardiol; 2015 Mar; 80():101-9. PubMed ID: 25584774
[TBL] [Abstract][Full Text] [Related]
7. Heat shock transcription factor 1 protects against pressure overload-induced cardiac fibrosis via Smad3.
Zhou N; Ye Y; Wang X; Ma B; Wu J; Li L; Wang L; Wang DW; Zou Y
J Mol Med (Berl); 2017 Apr; 95(4):445-460. PubMed ID: 28091697
[TBL] [Abstract][Full Text] [Related]
8. Antiinflammatory effects of the ETS factor ERG in endothelial cells are mediated through transcriptional repression of the interleukin-8 gene.
Yuan L; Nikolova-Krstevski V; Zhan Y; Kondo M; Bhasin M; Varghese L; Yano K; Carman CV; Aird WC; Oettgen P
Circ Res; 2009 May; 104(9):1049-57. PubMed ID: 19359602
[TBL] [Abstract][Full Text] [Related]
9. Crosstalk between endothelial cell-specific calpain inhibition and the endothelial-mesenchymal transition via the HSP90/Akt signaling pathway.
Sun X; Sun Y; Jiang P; Qi G; Chen X
Biomed Pharmacother; 2020 Apr; 124():109822. PubMed ID: 31958767
[TBL] [Abstract][Full Text] [Related]
10. Endothelium-specific endothelin-1 expression promotes pro-inflammatory macrophage activation by regulating miR-33/NR4A axis.
Zhang J; Zhao WS; Xu L; Wang X; Li XL; Yang XC
Exp Cell Res; 2021 Feb; 399(1):112443. PubMed ID: 33340492
[TBL] [Abstract][Full Text] [Related]
11. PKC-Mediated Endothelin-1 Expression in Endothelial Cell Promotes Macrophage Activation in Atherogenesis.
Zhang J; Wang YJ; Wang X; Xu L; Yang XC; Zhao WS
Am J Hypertens; 2019 Aug; 32(9):880-889. PubMed ID: 31111864
[TBL] [Abstract][Full Text] [Related]
12. A novel role of kallikrein-related peptidase 8 in the pathogenesis of diabetic cardiac fibrosis.
Du JK; Yu Q; Liu YJ; Du SF; Huang LY; Xu DH; Ni X; Zhu XY
Theranostics; 2021; 11(9):4207-4231. PubMed ID: 33754057
[No Abstract] [Full Text] [Related]
13. Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1.
Akamata K; Asano Y; Aozasa N; Noda S; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sato S
Arthritis Res Ther; 2014 Apr; 16(2):R86. PubMed ID: 24708674
[TBL] [Abstract][Full Text] [Related]
14. CTRP15 derived from cardiac myocytes attenuates TGFβ1-induced fibrotic response in cardiac fibroblasts.
Zhao Q; Zhang CL; Xiang RL; Wu LL; Li L
Cardiovasc Drugs Ther; 2020 Oct; 34(5):591-604. PubMed ID: 32424654
[TBL] [Abstract][Full Text] [Related]
15. Kaempferol Alleviates Angiotensin II-Induced Cardiac Dysfunction and Interstitial Fibrosis in Mice.
Liu Y; Gao L; Guo S; Liu Y; Zhao X; Li R; Yan X; Li Y; Wang S; Niu X; Yao L; Zhang Y; Li L; Yang H
Cell Physiol Biochem; 2017; 43(6):2253-2263. PubMed ID: 29073623
[TBL] [Abstract][Full Text] [Related]
16. Cytokine-Mediated Degradation of the Transcription Factor ERG Impacts the Pulmonary Vascular Response to Systemic Inflammatory Challenge.
Schafer CM; Martin-Almedina S; Kurylowicz K; Dufton N; Osuna-Almagro L; Wu ML; Johnson CF; Shah AV; Haskard DO; Buxton A; Willis E; Wheeler K; Turner S; Chlebicz M; Scott RP; Kovats S; Cleuren A; Birdsey GM; Randi AM; Griffin CT
bioRxiv; 2023 Feb; ():. PubMed ID: 36798267
[TBL] [Abstract][Full Text] [Related]
17. Profibrotic effects of endothelin-1 via the ETA receptor in cultured human cardiac fibroblasts.
Hafizi S; Wharton J; Chester AH; Yacoub MH
Cell Physiol Biochem; 2004; 14(4-6):285-92. PubMed ID: 15319532
[TBL] [Abstract][Full Text] [Related]
18. Endothelial Klf2-Foxp1-TGFβ signal mediates the inhibitory effects of simvastatin on maladaptive cardiac remodeling.
Li H; Wang Y; Liu J; Chen X; Duan Y; Wang X; Shen Y; Kuang Y; Zhuang T; Tomlinson B; Chan P; Yu Z; Cheng Y; Zhang L; Liu Z; Zhang Y; Zhao Z; Zhang Q; Liu J
Theranostics; 2021; 11(4):1609-1625. PubMed ID: 33408770
[No Abstract] [Full Text] [Related]
19. Inhibition of BRD4 attenuates transverse aortic constriction- and TGF-β-induced endothelial-mesenchymal transition and cardiac fibrosis.
Song S; Liu L; Yu Y; Zhang R; Li Y; Cao W; Xiao Y; Fang G; Li Z; Wang X; Wang Q; Zhao X; Chen L; Wang Y; Wang Q
J Mol Cell Cardiol; 2019 Feb; 127():83-96. PubMed ID: 30529267
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte growth factor reduces cardiac fibrosis by inhibiting endothelial-mesenchymal transition.
Okayama K; Azuma J; Dosaka N; Iekushi K; Sanada F; Kusunoki H; Iwabayashi M; Rakugi H; Taniyama Y; Morishita R
Hypertension; 2012 May; 59(5):958-65. PubMed ID: 22392903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
